This announcement is a separate document:
浙江华康药业股份有限公司向不特定对象发行可转换公司债券第一次临时受托管理事务报告（2024年度）
Zhejiang Huakang Pharmaceutical Co., Ltd. issued a first temporary trustee management report (2024) for convertible corporate bonds to unspecified parties.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.